DEVINN WOLFE: Open Payments
NPI 1497206908 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,113 in 138 payments from 28 companies in 2025. Trend: 2023 $2,664 · 2024 $2,718 · 2025 $3,113
Food & beverage: $3,082Education: $31
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $683 |
| Novo Nordisk Inc | 18 | $374 |
| Xeris Pharmaceuticals, Inc. | 11 | $236 |
| Amgen Inc. | 16 | $234 |
| Corcept Therapeutics | 11 | $233 |
| Lilly USA, LLC | 11 | $198 |
| Sequel Med Tech, LLC | 7 | $159 |
| Insulet Corporation | 5 | $129 |
| ABBVIE INC. | 7 | $102 |
| Ascendis Pharma Endocrinology Inc | 5 | $96 |
Products named: FREESTYLE LIBRE 3, Korlym, Ozempic, MOUNJARO, EVENITY, TWIIST, RECORLEV, Omnipod.
Industry payments across TN — which companies pay providers there.
